Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase
- PMID: 15905173
- DOI: 10.1074/jbc.M504045200
Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase
Abstract
Here we demonstrate that mammalian target of rapamycin (mTOR) is phosphorylated in a rapamycin-sensitive manner. We show that S6 kinase 1 (S6K1), but not Akt, directly phosphorylates mTOR in cell-free in vitro system and in cells. Expression of a constitutively active, rapamycin- and wortmannin-resistant S6K1 leads to constitutive phosphorylation of mTOR, whereas knock-down of S6K1 using small inhibitory RNA greatly reduces mTOR phosphorylation despite elevated Akt activity. Importantly, phosphorylation of mTOR by S6K1 occurs at threonine 2446/serine 2448. This region has been shown previously to be part of a regulatory repressor domain. These sites are also constitutively phosphorylated in the breast cancer cell line MCF7 carrying an amplification of the S6K1 gene, but not in a less tumorigenic cell line, MCF10a. Many models for Akt signaling to mTOR have been presented, suggesting direct phosphorylation by Akt. These models must be reconsidered in light of the present findings.
Similar articles
-
Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland.J Biol Chem. 2003 Jun 13;278(24):21960-71. doi: 10.1074/jbc.M300805200. Epub 2003 Mar 30. J Biol Chem. 2003. PMID: 12668683
-
Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site.J Biol Chem. 2002 May 31;277(22):20104-12. doi: 10.1074/jbc.M201745200. Epub 2002 Mar 25. J Biol Chem. 2002. PMID: 11914378
-
Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.Endocrinology. 2005 Mar;146(3):1473-81. doi: 10.1210/en.2004-0921. Epub 2004 Dec 16. Endocrinology. 2005. PMID: 15604215
-
The mammalian target of rapamycin signaling network and gene regulation.Curr Opin Lipidol. 2005 Jun;16(3):317-23. doi: 10.1097/01.mol.0000169352.35642.06. Curr Opin Lipidol. 2005. PMID: 15891393 Review.
-
In search of antiaging modalities: evaluation of mTOR- and ROS/DNA damage-signaling by cytometry.Cytometry A. 2014 May;85(5):386-99. doi: 10.1002/cyto.a.22452. Epub 2014 Feb 22. Cytometry A. 2014. PMID: 24677687 Free PMC article. Review.
Cited by
-
MicroRNA-214 Reduces Insulin-like Growth Factor-1 (IGF-1) Receptor Expression and Downstream mTORC1 Signaling in Renal Carcinoma Cells.J Biol Chem. 2016 Jul 8;291(28):14662-76. doi: 10.1074/jbc.M115.694331. Epub 2016 May 13. J Biol Chem. 2016. PMID: 27226530 Free PMC article.
-
S6 kinase 1 at the central node of cell size and ageing.Front Cell Dev Biol. 2022 Aug 12;10:949196. doi: 10.3389/fcell.2022.949196. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36036012 Free PMC article. Review.
-
FOXP1 regulation via the PI3K/Akt/p70S6K signaling pathway in breast cancer cells.Oncol Lett. 2015 Mar;9(3):1482-1488. doi: 10.3892/ol.2015.2885. Epub 2015 Jan 16. Oncol Lett. 2015. PMID: 25663935 Free PMC article.
-
Four-week rapamycin treatment improves muscular dystrophy in a fukutin-deficient mouse model of dystroglycanopathy.Skelet Muscle. 2016 Jun 2;6:20. doi: 10.1186/s13395-016-0091-9. eCollection 2016. Skelet Muscle. 2016. PMID: 27257474 Free PMC article.
-
eIF3f: a central regulator of the antagonism atrophy/hypertrophy in skeletal muscle.Int J Biochem Cell Biol. 2013 Oct;45(10):2158-62. doi: 10.1016/j.biocel.2013.06.001. Epub 2013 Jun 13. Int J Biochem Cell Biol. 2013. PMID: 23769948 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous